Page 133 - 30917_ASHG_Complete

This is a SEO version of 30917_ASHG_Complete. Click here to view full version

« Previous Page Table of Contents Next Page »
Friday, October 14
10:30
AM
–12:30
PM
Concurrent Invited Session III (45-50)
SESSION 50 – Exploring International Approaches to
the Evaluation of Genetics Education
Room 511, Level 5, Convention Center
Moderators:
Kate Reed, NCHPEG, Lutherville, MD,
USA; Victor B. Penchaszadeh, Ctr. for Genet. and
Publ. Hlth., Buenos Aires, Argentina
A recent focus on genetics education in medicine and
public health has resulted in a large number of
educational programs for a variety of audiences. A
challenge that has not been addressed with as much
enthusiasm is the evaluation of the effectiveness of
these programs. Physicians, scientists, politicians,
public health workers, and consumers are calling for
accurate and accessible information about the impact
of genetic and genomic discoveries on society and the
individual worldwide. In addition, funders have
increased attention on evaluation. There is, therefore, a
significant need for robust and sustainable educational
resources that improve knowledge and influence
behavior. An understanding of the most effective ways
to educate different health professional audiences and
determine appropriate outcomes and measures is
essential to facilitating the implementation of genetics
into clinical settings worldwide. This program will
convene experts in the evaluation of genetics
education for health professionals. The speakers will
describe their educational programs and will explore
different approaches to evaluation of content,
pedagogy, delivery mechanisms, and clinical outcomes
as they apply to diverse groups of clinicians, including
practitioners and pre-clinical trainees (e.g., medical
students, nursing students), in Africa, Australia, the
Middle East, South America, the United Kingdom, and
the United States.
10:30
AM
Introduction.
K. Reed. NCHPEG,
Lutherville, MD, , USA.
10:35
AM
Educating a country: Genetics education
for health professionals in the United Kingdom.
P.
Farndon. Natl. Genet. Educ. and Develop. Ctr.,
Edgbaston, Birmingham, U.K.
10:55
AM
Evaluating genetic education in Latin
America.
V. B. Penchaszadeh. Ctr. for Genet. and
Publ. Hlth., Buenos Aires, Argentina.
11:15
AM
Genetics education and program
evaluation in Australia.
S. Metcalfe. Univ. of
Melbourne, Australia.
11:35
AM
Developing and evaluating genetics
education in developing countries.
H. Hamamy.
Geneva Univ. Hosp., Vernier, Switzerland.
11:55
AM
Development of a novel evaluation
approach for genetics education in the United
States.
E. Edelman. NCHPEG, Lutherville, MD, USA.
12:15
PM
Questions and answers.
V. B.
Penchaszadeh. Ctr. for Genet. and Publ. Hlth., Buenos
Aires, Argentina.
Cameras and all other recording devices are
strictly prohibited
in all session rooms. Thank you for your cooperati
Friday, October 14
4:15
PM
–6:15
PM
Concurrent Platform Session C (51-60
SESSION 51 – Cancer Genetics II: Ovarian and Breas
Room 210, Level 2, Convention Center
Moderators:
Hidewaki Nagakawa, Ctr. for Genomic
Med., Japan; William Foulkes, McGill Univ. Hlth. Ctr.
Canada
163
/4:15
Functional polymorphisms in the
TERT
promoter are associated with risk of epithelial
ovarian cancer.
G. Chenevix-Trench, J. Beesley, H.
Pickett, S. Johnatty, X. Chen, D. Rider, M. Stutz, D.
Lambrechts, J. Chang-Claude, T. Dork, M. T.
Goodman, B. Kiemney, E. Bandera, L. S. Cook, N. L
I. Campbell, S. Gayther, S. Ramus, S. Macgregor, E.
Goode, R. Reddel on behalf of the Ovarian Cancer
Association Consortium.
164
/4:30
Massively parallel sequencing identifies
inherited mutations in 12 genes in women with
ovarian, peritoneal, and fallopian tube carcinoma
T. Walsh, S. Casadei, M. Lee, C. Pennil, A. Nord, A.
Thornton, W. Roeb, M.-C. King, E. Swisher.
165
/4:45
Ovarian cancer susceptibility loci and ri
of ovarian cancer in
BRCA1
and
BRCA2
carriers.
J. Ramus, A. C. Antoniou, K. Kuchenbaecker, P.
Soucy, L. McGuffog, S. Healey, O. M. Sinilnikova, P.
Radice, D. E. Goldgar, S. Peock, R. K. Schmutzler,
Stoppa-Lyonnet, M. A. Rookus, A. Jakubowska,
kConFab. Investigators, J. Simard, D. F. Easton, F.
Couch, G. Chenevix-Trench on behalf of Consortium
of Investigators of Modifiers of BRCA1/2.
166
/5:00
Evaluation of transcripts generated by
germline mutations identified by massively parall
genomic sequencing in ovarian cancer patients.
Casadei, T. Walsh, M. Lee, A. Nord, S. Stray, A.
Thornton, C. Pennil, A. Wickramanayake, B. Norquis
M. C. King, E. Swisher.
167
/5:15
Discovery of new genes for inherited
breast cancer by exome sequencing of unresolve
high-risk families.
C. Spurrell, M. Lee, A. Nord, S.
Casadei, A. Thornton, J. Mandell, T. Walsh, M.-C.
King.
168
/5:30
Common breast cancer susceptibility
alleles are associated with tumor subtypes in
BRCA1
and
BRCA2
mutation carriers: Results fro
the Consortium of Investigators of Modifiers of
BRCA1/2
.
A. C. Antoniou, A. M. Mulligan, F. J. Cou
D. Barrowdale, S. M. Domchek, D. Eccles, H.
Nevanlinna, S. J. Ramus, M. Robson, M. Sherman,
B. Spurdle, B. Wappenschmidt, L. McGuffog, J.
Simard, G. Chenevix-Trench, D. F. Easton, I. L.
Andrulis on behalf of Consortium of Investigators of
Modifiers of BRCA1/2.